期刊文献+

mRNA Expression of Chemokine Receptors on Peripheral Blood Mononuclear Cells and Correlation with Clinical Features in Systemic Lupus Erythematosus Patients 被引量:2

mRNA Expression of Chemokine Receptors on Peripheral Blood Mononuclear Cells and Correlation with Clinical Features in Systemic Lupus Erythematosus Patients
在线阅读 下载PDF
导出
摘要 Objective To investigate the expressions of chemokine receptors and interleukin (IL) receptors on the peripheral blood mononuclear cells (PBMCs) from systemic lupus erythematosus (SLE) patients and their correlations with clinical features as well as SLE disease activity index (SLEDAI). Methods The mRNA expressions of chemokine receptors and IL receptors on PBMCs of 93 SLE patients and 30 healthy controls were detected by reverse transcription-polymerase chain reaction, including CCR2, CCR3, CCR4, CCR5, CCR6, CCR8, CXCR3, CXCR5, CX3CR1, XCR1, IL-4R, and IL-10R. The clinical features of SLE patients were recorded. The correlations of chemokine receptors and IL receptors mRNA expressions with clinical features as well as SLEDAI were assayed using linear regression analysis. Results The level of CCR5 mRNA in SLE patients (including active and inactive SLE) was signifi- cantly higher than that in healthy controls (P〈0.05), and there was no significant difference between active and inactive patients in this respect (P〉0.05). CX3CR1 mRNA expression significantly increased from healthy control to inactive SLE to active SLE in sequence. The others (except for CCR8, CXCR3, and IL-1 OR) in active SLE patients weresignificantly higher than those in both inactive SLE patients and healthy controls (all P〈0.05). There were positive correlations between SLEDAI and CCR2 (r=0.424, t=4.313, P〈0.001), CCR3 (r=0.518, t=5.410, P〈0.001), CCR4 (r=0.376, t=3.851, P〈0.001), CCR6 (r=0.457, t=4.513,P〈0.001), CXCR5 (r=0.455, t=4.629, P〈0.001), CX3CR1 (r=0.44-5, t=4.523, P〈0.001), as well as XCRI (r=0.540, t=5.445, P〈0.001). And CCR5 mRNA expression level was positively correlated with IL-4R mRNA (r=0.313, t=2.353, P〈0.05). The patients with myositis and cutaneous vasculitis simultaneously showed lower levels of CCR5 and CX3CRI, and CCR5 expression was negatively correlated with the scores of SLEDAI in SLE cases accompanied by photosensitivity (r=0.426, t=- 2.155, P〈0.05). Conclusion Increased expressions of CCR5 and CX3CRI on PBMCs may be indicators in clinical survey for SLE.
出处 《Chinese Medical Sciences Journal》 CAS CSCD 2010年第3期162-168,共7页 中国医学科学杂志(英文版)
基金 Supported by National Natural Science Foundation of China (30170863 and 30771938) Natural Science Foundation of Jiangsu Province (BK2001195)
关键词 systemic lupus erythematosus chemokine receptors peripheral bloodmononuclear cell 外周血单个核细胞 系统性红斑狼疮 趋化因子受体 受体基因 临床特征 患者 mRNA表达 逆转录聚合酶链反应
  • 相关文献

参考文献24

  • 1Wallace DJ.The clinical presentation of systemic lupus erythematosus.In:Wallace D.1,Hahn BH,editors.Dubois' lupus erythematosus.5th ed.Baltimore (Maryland):Williams & Wilkins; 1997.p.627-33.
  • 2Rossi D,Zlotnik A.The biology of chemokines and their receptors.Ann Rev Immunol 2000; 18:217-42.
  • 3Zlotnik A,Yoshie O.Chemokines:a new classification system and their role in immunity.Immunity 2000; 12:121-7.
  • 4Lanzavecchia A,Sallusto F.Dynamics of T lymphocyte responses:intermediates,effectors,and memory cells.Science 2000; 290:92-7.
  • 5Sallusto F,Mackay CR,Lanzavecchia A.The role of chemokine receptors in primary,effector,and memory immune responses.Ann Rev'Immunol 2000; 18:593-620.
  • 6Luther SA,Cyster JG.Chemokines as regulators of T cell differentiation.Nat Immunol 2001; 2:102-7.
  • 7Gerard C,Rollins BJ.Chemokines and disease.Nat Immunol 2001; 2:108-15.
  • 8Mackay CR.Chemokines:immunology's high impact factors.Nat Immunol 2001; 2:95-101.
  • 9Stasikowska O,Danilewicz M,Wagrowska-Danilewicz M.The significant role of RANTES and CCR5 in progressive tubulointerstitial lesions in lupus nephropathy.Pol J Pathol 2007; 58:35-40.
  • 10Wenzel J,Proelss J,Wiechert A,et al.CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus.J Am Acad Dermatol 2007; 56:648-50.

同被引文献2

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部